Tempest Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.7M | $30.3M | $39.2M | $31.2M | $51.8M | $18.8M | $62.5M | $73.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $8.3M | $31.5M | $40.4M | $33.0M | $69.0M | $19.8M | $71.1M | $83.4M |
| Property, Plant & Equipment | $605.0K | $886.0K | $840.0K | $1.1M | $1.1M | $1.1M | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $16.9M | $41.5M | $51.6M | $46.1M | $73.2M | $22.9M | $75.0M | $84.1M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $2.5M | $845.0K | $1.1M | $991.0K | $1.1M | $1.5M | $2.0M |
| Total Current Liabilities | $3.3M | $14.2M | $9.4M | $7.3M | $20.0M | $3.2M | $12.5M | $9.8M |
| Long-Term Debt | — | $0 | $6.3M | $10.4M | $15.1M | $61.0K | $168.0K | $383.0K |
| Total Liabilities | $10.3M | $22.4M | $24.8M | $28.0M | $37.1M | $4.9M | $15.1M | $11.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-233.4M | $-207.1M | $-165.3M | $-135.8M | $-100.1M | $-71.8M | $-208.7M | $-164.1M |
| Total Stockholders' Equity | $6.7M | $19.1M | $26.8M | $18.1M | $36.1M | $-68.8M | $-50.4M | $71.0M |